Sino Biopharmaceutical Ltd (1177.HK)
Company Info
ISIN | KYG8167W1380 |
---|---|
Sector | Healthcare |
Industry | Biotechnology |
Highlights
Market Cap | HK$57.34B |
---|---|
EPS | HK$0.01 |
PE Ratio | 27.73 |
PEG Ratio | 0.49 |
Revenue (TTM) | HK$28.86B |
Gross Profit (TTM) | HK$21.53B |
EBITDA (TTM) | HK$6.95B |
Year Range | HK$2.57 - HK$4.62 |
Target Price | HK$4.65 |
Share Price Chart
Loading data...
Compare to other instruments
Popular comparisons: 1177.HK vs. 6078.HK
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Sino Biopharmaceutical Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Sino Biopharmaceutical Ltd had a return of -13.26% year-to-date (YTD) and -28.68% in the last 12 months. Over the past 10 years, Sino Biopharmaceutical Ltd had an annualized return of -7.06%, while the S&P 500 had an annualized return of 10.96%, indicating that Sino Biopharmaceutical Ltd did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -13.26% | 10.04% |
1 month | -4.75% | 3.53% |
6 months | 4.92% | 22.79% |
1 year | -28.68% | 32.16% |
5 years (annualized) | -15.17% | 13.15% |
10 years (annualized) | -7.06% | 10.96% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -19.02% | 11.39% | ||||||||||
2023 | -15.34% | -5.03% | 8.22% | 26.32% | -9.64% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for Sino Biopharmaceutical Ltd (1177.HK) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
Sino Biopharmaceutical Ltd | -0.73 | ||||
S&P 500 | 2.76 |
Dividends
Dividend History
Sino Biopharmaceutical Ltd granted a 2.66% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.08 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | HK$0.08 | HK$0.08 | HK$0.10 | HK$0.04 | HK$0.05 | HK$0.04 | HK$0.04 | HK$0.03 | HK$0.03 | HK$0.02 | HK$0.02 | HK$0.01 |
Dividend yield | 2.66% | 2.31% | 2.19% | 0.75% | 0.71% | 0.37% | 0.77% | 0.22% | 0.49% | 0.25% | 0.27% | 0.24% |
Monthly Dividends
The table displays the monthly dividend distributions for Sino Biopharmaceutical Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | HK$0.00 | HK$0.00 | ||||||||||
2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 |
2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.00 | HK$0.00 | HK$0.00 |
2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 |
2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.02 |
2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.01 |
2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.01 |
2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.01 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.01 | HK$0.00 |
2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.01 |
2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2014 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2013 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Sino Biopharmaceutical Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Sino Biopharmaceutical Ltd was 86.04%, occurring on Oct 4, 2023. The portfolio has not yet recovered.
The current Sino Biopharmaceutical Ltd drawdown is 84.20%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-86.04% | May 29, 2018 | 1318 | Oct 4, 2023 | — | — | — |
-81.11% | Apr 27, 2004 | 1064 | Oct 27, 2008 | 384 | May 14, 2010 | 1448 |
-54.98% | Nov 9, 2015 | 155 | Jun 24, 2016 | 341 | Nov 10, 2017 | 496 |
-52.11% | May 17, 2010 | 475 | Apr 17, 2012 | 165 | Dec 11, 2012 | 640 |
-38.05% | Oct 3, 2000 | 4 | Oct 9, 2000 | 93 | Feb 28, 2001 | 97 |
Volatility
Volatility Chart
The current Sino Biopharmaceutical Ltd volatility is 14.16%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |